Standard Uranium Ltd (TSX-V:STND, OTCQB:STTDF) told investors that it has commenced deploying the first-ever ExoSphere Multiphysics surveys in the southwest Athabasca Basin as part of ongoing exploration at its flagship Davidson River project, in partnership with Fleet Space Technologies.
The advanced surveys are designed to enhance subsurface imaging across high-priority uranium target corridors ahead of a planned summer drilling program, the company said on Wednesday.
Fineqia International Inc (CSE:FNQ, OTC:FNQQF) announced that it has appointed Psalion Operations Limited as an investment advisor to its Liechtenstein-based subsidiary, Fineqia AG, to support its strategy of developing of structured, yield-oriented crypto Exchange-Traded Products (ETPs) for investors across Europe.
Psalion Operations Limited is a subsidiary of the Psalion Group, a blockchain-focused investment firm with institutional expertise across the digital asset landscape.
NanoViricides (NYSE-A:NNVC) said its experimental antiviral drug NV-387 could play a role in combating emerging threats from COVID-19 and bird flu, as new virus variants raise global health concerns.
The company pointed to the rise of the COVID variant NB.1.8.1, or "Nimbus," which is spreading in the US and globally.
Petro Matad Limited (AIM:MATD, OTC:PRTDF) told investors it has now received US$ 1.18 million of oil sales proceeds from PetroChina.
This represents the first revenues from the Heron-1 well, on Block XX in Mongolia.
Coinsilium Group Limited (AQSE:COIN, OTCQB:CINGF) has successfully raised £4 million in its significantly oversubscribed retail offer.
The raise comes as the blockchain and crypto company is seeing a high degree of interest in its Bitcoin treasury venture, Forza.
Tiger Royalties and Investments (AIM: TIR) jumped 55% on Wednesday after revealing that its newly acquired Tiger Alpha Bittensor Subnet is generating nearly $70,000 in monthly revenue, just a month after going live.
The subnet, a revenue-generating node on the decentralised Bittensor blockchain, is producing over six TAO per day, worth more than $2,300 at current prices.
US$120 million in proposed funding from the Export-Import Bank of the United States (EXIM) is set to underpin the development of one of the world’s largest rare earth deposits— Critical Metals Corp’s, Tanbreez Project in Greenland. European Lithium Ltd (ASX:EUR, OTCQB:EULIF), which holds a 63% equity stake in Critical Metals, stands to benefit significantly from the funding proposal through its strategic exposure to the project’s future upside.
The conditional, non-binding Letter of Interest (LoI), issued to EUR subsidiary Critical Metals, marks a major milestone in advancing the project and bolstering Western supply chains for critical minerals.
archTIS Ltd (ASX:AR9, OTCQB:ARHLF) has signed a three-year contract worth A$263,185 with the UK division of a global aerospace and defence corporation to implement its NC Protect data security solution. The deployment, supporting an initial 400 users, will serve as a global model for Microsoft 365 cloud adoption across the client’s enterprise of over 100,000 employees.
This UK contract follows a recent win with the United States Department of Defense (DoD), reinforcing growing global demand for NC Protect in securing sensitive information across Western defence and industrial networks.
Ionic Rare Earths Ltd (ASX:IXR, OTC:IXRRF) is expanding the scope of its Brazilian joint venture, Viridion, to explore the development of a rare earth refinery in the United States, targeting a more secure and diversified global supply chain for critical magnet and heavy rare earth oxides (REOs).
The potential US facility would build on Viridion’s existing refining and recycling plans in Brazil, positioning the JV — owned 50/50 by IonicRE and Viridis Mining and Minerals Ltd (ASX:VMM) — as a key player in the ex-China rare earths supply chain across the Americas.
Imugene Ltd (ASX:IMU, OTC:IUGNF) Ltd has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application covering the onCARlytics oncolytic virotherapy platform, CF33-CD19. The approval secures protection for the method of composition and method of use of the technology until August 10, 2038.
The patent, titled Oncolytic Virus Expressing a CAR T Cell Target and Uses Thereof, marks a strategic advance in the US, the largest healthcare and oncology market globally. It follows a similar allowance in China earlier this year, reinforcing Imugene’s growing intellectual property position in major therapeutic regions.
Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) Ltd is accelerating the development of its Horse Heaven Antimony-Gold-Silver-Tungsten Project in Idaho by aligning with the United States Government’s critical minerals strategy. The company has engaged Washington, D.C.-based advisers, Clewett Global Services, to support a targeted government engagement program, including pursuit of funding opportunities and expedited permitting pathways.
With growing geopolitical tensions and China’s late-2024 export ban on key minerals, the US has prioritised domestic and allied supply chains for strategic resources such as antimony and tungsten. RML is actively seeking inclusion in the FAST-41 permitting program and intends to apply for potential funding under the US Department of Defense and forthcoming 2025 Budget Reconciliation Bill, which earmarks billions for critical mineral supply chain development.